HIMS stock soars to all-time high, reaching $46.11

Published 02/12/2025, 03:28 PM
HIMS stock soars to all-time high, reaching $46.11

In a remarkable display of market confidence, HIMS & Hers Health, Inc. (HIMS) stock has soared to an all-time high, with shares hitting a peak of $46.11. This milestone underscores the company's significant growth trajectory and investor optimism in its business model, with the company now commanding a market capitalization of over $10 billion. While HIMS celebrates this record-setting price level, another notable market mover, Oaktree Acquisition Corp (NYSE:HIMS), has experienced a staggering 385.02% change over the past year. This impressive performance highlights a period of intense activity and bullish sentiment in the health and wellness sector, as investors continue to seek out innovative companies with strong potential for sustained growth. For deeper insights into HIMS's valuation and 18 additional expert tips, investors can access the comprehensive Pro Research Report available on InvestingPro.

In other recent news, Hims & Hers Health has been the focus of various developments. The company's recent Super Bowl ad, which promoted its weight loss product, has led to increased investor sentiment and a significant uptick in web traffic, according to Craig-Hallum analyst Alex Furhman. Despite facing criticism over the same ad, the company's shares climbed, reflecting investor confidence in its business model.

On the analyst front, BofA Securities maintained an Underperform rating on Hims & Hers Health, highlighting concerns about the future of the company's compounded GLP-1 products due to aggressive defense tactics by pharmaceutical manufacturers. In contrast, BTIG initiated coverage on the company with a Buy rating, citing its innovative business model and anticipated robust revenue growth, particularly in the GLP-1 and obesity health product categories.

Needham & Company also showed confidence in Hims & Hers Health, raising their price target on the company's shares and naming it their top pick in the digital health sector for 2025. They underscored the company's potential for growth and its focus on personalized product adoption and weight loss solutions. These developments highlight the evolving landscape for Hims & Hers Health as it navigates the challenges and opportunities in the healthcare market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.